自我监测血糖设备市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品、按应用、最终用户、地区、竞争细分

2022 年，全球自我监测血糖设备市场价值为 184 亿美元，预计在预测期内将实现强劲增长，到 2028 年复合年增长率为 8.2%。血糖监测在帮助糖尿病患者在食物摄取、胰岛素剂量和体育锻炼方面做出明智的日常管理决策。自我监测血糖（SMBG）代表了一种当代糖尿病管理程序，患者使用血糖仪快速检查其血糖水平并获得毛细血管葡萄糖浓度的准确测量。 SMBG 技术包括试纸、刺血针和血糖仪，有助于长期血糖控制。透过分析读数，个人可以调整治疗，评估抗糖尿病药物和压力管理的影响，并就饮食、胰岛素剂量和体能活动等因素做出明智的决定。这个综合过程涉及利用试纸、刺血针和血糖仪来实现持续的血糖控制。

主要市场驱动因素：

糖尿病的高盛行率：老年人口的增加和糖尿病的高盛行率，以及与糖尿病相关的危险因子的增加，是血糖自我监测（SMBG）市场成长的关键驱动力。此外，旨在提高民众意识的政府措施也有助于市场的成长。然而，应该注意的是，这些设备不能测量血液中准确的葡萄糖水平，这可能会导致结果不准确。此外，这些设备缺乏报销和严格的监管可能会阻碍整体市场的成长。

市场概况
预测期	2018-2028
2022 年市场规模	97.3亿美元
2028 年市场规模	156.6亿美元
2023-2028 年复合年增长率	8%
成长最快的细分市场	2型糖尿病
最大的市场	北美洲

儘管有这些挑战，新兴市场仍有尚未开发的机会，人们对糖尿病监测设备的认识不断增强，预计将在预测期内产生新的前景。然而，缺乏患者意识以及先进设备和配件的高成本等挑战预计将阻碍市场的成长。

技术进步

技术进步彻底改变了血糖监测设备市场，提高了准确性、使用者友善性以及与医疗保健提供者的连接性。例如，连续血糖监测 (CGM) 系统提供即时血糖读数和趋势，以最大限度地减少频繁的指尖采血测试的需要。行动应用程式和无线连接的整合增强了资料管理并改善了患者治疗结果。 Abbott Laboratories、Medtronic plc、Roche Diabetes Care、Dexcom, Inc. 和 Ascensia Diabetes Care Holdings AG 等领先市场参与者正在投资研发以推出创新产品。血糖监测设备市场受到严格的监管，以确保患者安全和设备功效，设备审批和上市后监督由 FDA 和 EMA 监督。血糖监测设备领域技术进步的崛起正在推动全球市场的成长。随着技术的进步，这些设备现在可以以不同的形式、尺寸和测试持续时间广泛使用。紧凑型和便携式设备的发展有利于方便操作，从而增加了需求。此外，医学进步有助于早期发现高血糖和低血糖糖尿病，从而进一步推动全球市场的成长。

肥胖病例不断增加

生活方式的改变以及酗酒和吸烟的流行导致糖尿病病例持续增加，从而导致对此类设备的需求增加。肥胖率不断上升进一步推动了全球自我监测血糖设备市场的成长。此外，全球老年人口的不断增长也推动了市场的成长。个人对糖尿病预防保健的认识不断提高是全球市场扩张的关键驱动力。然而，冠状病毒的爆发严重影响了人们的生活方式，封锁措施将活跃的行为转变为久坐的行为。因此，这些因素导致糖尿病病例增加，并随后增加了对此类设备的需求。旨在减少糖尿病病例的政府措施激增，对整个预测期内全球自我监测血糖设备市场的发展轨迹产生了积极影响。

老年人口数量不断增加

人口老化更容易患糖尿病。自我血糖监测设备满足了老年人的需求，使他们能够独立有效地管理糖尿病。随着年龄的增长，他们的细胞对胰岛素的敏感性可能会降低，从而导致胰岛素阻抗。这种敏感性的降低使得身体有效调节血糖水平更具挑战性。许多老年人可能会采取更多久坐的生活方式，这会导致体重增加并恶化胰岛素阻抗。长年不健康的饮食习惯会导致肥胖和代谢紊乱，增加第二型糖尿病的风险。自我血糖监测设备使老年人可以在家中或在旅途中检查自己的血糖水平。定期监测有助于他们追踪自己的病情并对治疗计划进行必要的调整。借助自我监测设备，老年人可以独立管理糖尿病，减少对他人日常监测的依赖。

主要市场挑战

合规性和遵守性

定期和持续的血糖监测对于有效的糖尿病管理至关重要。然而，有些人可能会因为健忘、与测试相关的不适或缺乏动力而难以坚持。正确使用自我监测血糖设备需要一定程度的技术技能和知识。一些老年人或灵活性有限的人可能会发现正确操作设备具有挑战性。自我监测血糖设备需要精确校准和维护才能提供可靠的结果。不正确的校准或使用过期的试纸可能会导致读数不准确。

新兴国家的诊断率低

大量未确诊的糖尿病患者是血糖监测系统采用率较低的主要因素，特别是在新兴国家。与已开发国家相比，中国、印度、南非、巴西等国家的延迟诊断率更高。此外，一般民众对糖尿病等慢性病的认识有限，加上先进医疗基础设施的使用受到限制以及政府或私人组织的传统程序不足，可能会阻碍成长。

例如，根据国际糖尿病联盟2021年发布的资料，非洲近一半的糖尿病患者仍未确诊，而在亚太地区，未确诊的糖尿病患者比例约为55.0%，这主要是由以下国家推动的：印度、中国和印尼。因此，上述因素，加上 CGM 和 SMBG 系统缺乏报销计划，极大地导致了诊断和治疗率的降低，从而限制了这些系统在发展中国家的实施。

主要市场趋势

新产品上市

自我监测血糖 (SMBG) 设备市场中的知名公司都策略性地专注于开发创新技术解决方案，以增强其市场地位。例如，2022 年 8 月，致力于简化糖尿病患者生活的商业阶段医疗技术和数位健康公司 Intuity Medical, Inc. 在 Kroger Health 运营的 2,200 多家美国药局推出了 POGO 自动 (R) 血糖监测系统Intuity Medical 的POGO 自动血糖监测仪是唯一一款获得FDA 批准的自动血糖监测仪，采用10 项测试盒技术，使糖尿病患者无需携带或装载单独的刺血针和试纸条。只需按一下按钮，它就能毫不费力地进行采血、采集血液并提供血糖结果。

增加资金和投资

增加资金和投资将促进研究和开发活动以及新技术的进步和项目。市场参与者正在寻求旨在数位转型的资金和投资，以提高效率。例如，2022 年 9 月，致力于加强慢性病预防、诊断和管理的英国技术平台 Transdermal Diagnostics 宣布成功完成超额认购的 110 万英镑（131 万美元）种子前投资。这笔资金将用于开发一种具有成本效益的 100% 无针血糖监测仪，改善人们负担得起的血糖监测的机会，并帮助糖尿病患者过上更长寿、更健康的生活。借助透皮诊断新技术，糖尿病患者可以透过无痛监测血糖值来减缓甚至停止病情的进展。此外，2022 年 5 月，全球领先的生命科学公司和商业实验室 Labcorp 推出了一款家用采集套件，可测量血红蛋白 A1c，并使用少量血液样本评估糖尿病的风险。

细分市场洞察

最终使用者见解

在基础设施改善和医院医疗保健支出增加的推动下，预计医院领域将在预测期内主导市场。此外，BGM 设备可以在几秒钟内为医生提供可靠的资料，从而提高门诊和住院患者的护理品质。医院还拥有储存和传输患者资讯的健全规定。此外，为了因应 COVID-19 大流行，FDA 授权在医院使用 CGM 设备，未来大流行的可能性预计将进一步推动该细分市场的成长。

应用洞察

从应用来看，市场可分为妊娠期糖尿病、第2型糖尿病和第1型糖尿病。 2型糖尿病在全球自我监测血糖设备市场中占有最大的市场份额。这是一种慢性、终身疾病，影响糖水平的处理和监测。 2 型糖尿病是最常见的糖尿病形式，占全球糖尿病病例的大多数。 2 型糖尿病盛行率不断上升，特别是由于久坐习惯、不健康饮食和肥胖等生活方式因素，导致自我监测血糖设备市场不断扩大。有效管理第 2 型糖尿病需要定期监测血糖。自我监测血糖设备在帮助 2 型糖尿病患者追踪血糖水平并对其治疗计划进行必要调整方面发挥着至关重要的作用，从而促进了市场的成长。

区域洞察

在美国，糖尿病患者的发生率和盛行率不断上升，以及医疗保健支出显示自我监测血糖 (SMBG) 设备的使用越来越多。受 SMBG 设备的广泛使用、消费者认知度高和有利的报销政策等因素的推动，北美预计将成为主导市场。过去二十年来，北美糖尿病盛行率大幅上升，这主要归因于肥胖盛行率的增加和生活方式的改变。此外，该地区的碳水化合物消耗量较高，这导致肥胖率上升。美国是北美地区慢性病快速成长的国家之一，也是SMBG设备最大的需求国。

主要市场参与者

• 雅培实验室
• 美敦力公司
• F.霍夫曼-拉罗氏有限公司
• Ascensia 糖尿病护理
• 德克斯康沃尔
• 赛诺菲
• 诺和诺德
• 英苏莱特公司
• 伊普索梅德控股公司
• 格莱森斯公司

可用的客製化：

全球自我监测血糖设备市场报告根据给定的市场资料，Tech Sci Research 根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球自我监测血糖设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产品（自我监测血糖仪、连续血糖监测仪、试纸、采血针）
  • 按应用（1 型糖尿病、2 型糖尿病、妊娠期糖尿病）
  • 按最终使用者（医院、家庭设定和诊断中心）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美自我监测血糖设备市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲自我监测血糖设备市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区自我监测血糖设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲自我监测血糖设备市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲自我监测血糖设备市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按应用
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非自我监测血糖设备
  • 沙乌地阿拉伯自我监测血糖设备
  • 阿联酋自我监测血糖设备

第 11 章：市场动态

第 12 章：市场趋势与发展

第 13 章：全球自我监测血糖设备市场：SWOT 分析

第14章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 主要人员
• SWOT分析
  • Abbott Laboratories
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd
  • Ascensia Diabetes Care
  • Dexcom, Inc.
  • Sanofi
  • Novo Nordisk
  • Insulet Corporation
  • Ypsomed Holdings
  • Glysens Incorporated

第 15 章：策略建议

第 16 章：关于我们与免责声明

The Global Self-monitoring Blood Glucose Devices Market was valued at USD 18.4 billion in 2022 and is projected to experience robust growth in the forecast period, with a CAGR of 8.2% through 2028. Blood glucose monitoring plays a crucial role in empowering diabetic patients to make well-informed daily management decisions regarding food intake, insulin dosage, and physical exercise. Self-monitoring blood glucose (SMBG) represents a contemporary diabetes management procedure that involves the use of blood glucose meters by patients to quickly check their glucose levels and obtain accurate measurements of capillary glucose concentration. SMBG technology, encompassing test strips, lancets, and blood glucose meters, facilitates long-term glycemic control. By analyzing readings, individuals can adjust treatment, evaluate the impact of antidiabetic medications and stress management, and make informed decisions regarding diet, insulin dosage, and physical exercise, among other factors. This comprehensive process involves the utilization of test strips, lancets, and blood glucose meters to achieve sustained glycemic control.

Key Market Drivers:

High Prevalence of Diabetes: The increase in the geriatric population and the high prevalence of diabetes, along with the rising risk factors associated with diabetes, are key drivers for the growth of the self-monitoring of blood glucose (SMBG) market. Furthermore, government initiatives aimed at raising awareness among the population also contribute to the market's growth. However, it should be noted that the devices do not measure the exact level of glucose in the blood, which can result in inaccurate results. Moreover, the lack of reimbursement and stringent regulations for these devices may hinder the overall market growth.

Market Overview
Forecast Period	2018-2028
Market Size 2022	USD 9.73 Billion
Market Size 2028	USD 15.66 Billion
CAGR 2023-2028	8%
Fastest Growing Segment	Type 2 Diabetes
Largest Market	North America

Despite these challenges, there are untapped opportunities in emerging markets, and the growing awareness about diabetes monitoring devices is expected to generate new prospects within the forecast period. However, challenges such as the lack of patient awareness and the high cost of advanced devices and accessories are projected to impede the market's growth.

Technological Advancement

Technological advancements have revolutionized the blood glucose monitoring devices market, enhancing accuracy, user-friendliness, and connectivity with healthcare providers. Continuous Glucose Monitoring (CGM) systems, for instance, offer real-time glucose readings and trends, minimizing the need for frequent fingerstick tests. The integration of mobile apps and wireless connectivity has bolstered data management and improved patient outcomes. Leading market players such as Abbott Laboratories, Medtronic plc, Roche Diabetes Care, Dexcom, Inc., and Ascensia Diabetes Care Holdings AG are investing in research and development to introduce innovative products. Stringent regulations govern the blood glucose monitoring devices market to ensure patient safety and device efficacy, with device approval and post-market surveillance overseen by the FDA and EMA. The rise in technological advancements in the field of blood glucose monitoring devices is driving the growth of the global market. With advancing technology, these devices are now widely accessible in different forms, sizes, and testing durations. The development of compact and portable devices facilitates convenient handling, thereby increasing demand. Furthermore, medical advancements contribute to the early detection of hyper and hypoglycemic diabetes, thus further fueling global market growth.

Rising Cases of Obesity

The changing lifestyle and increasing prevalence of alcohol and smoking consumption have contributed to a continuous rise in diabetes cases, resulting in a heightened demand for such devices. The escalating rates of obesity further drive the growth of the global self-monitoring blood glucose devices market. Additionally, the expanding geriatric population worldwide is fueling market growth. The growing awareness among individuals regarding preventive care for diabetes is a key driver for the global market's expansion. However, the outbreak of the coronavirus has significantly impacted people's lifestyles, with lockdown measures transforming active behaviors into sedentary ones. Consequently, these factors have led to an increase in diabetes cases and subsequently boosted the demand for such devices. The surge in government initiatives aimed at reducing diabetes cases has positively influenced the trajectory of the global self-monitoring blood glucose devices market throughout the forecast period.

Rising Number of Geriatric Population

The aging population is more susceptible to developing diabetes. Self-monitoring blood glucose devices cater to the needs of elderly individuals, allowing them to manage their diabetes independently and efficiently. s people age, their cells may become less sensitive to insulin, leading to insulin resistance. This reduced sensitivity makes it more challenging for the body to regulate blood glucose levels effectively. Many older adults may lead more sedentary lifestyles, which can contribute to weight gain and worsen insulin resistance. Unhealthy eating habits over the years can lead to obesity and metabolic disorders, increasing the risk of type 2 diabetes. elf-monitoring blood glucose devices allow older adults to check their blood glucose levels at home or on the go. Regular monitoring helps them track their condition and make necessary adjustments to their treatment plan. With self-monitoring devices, elderly individuals can manage their diabetes independently, reducing their dependence on others for daily monitoring.

Key Market Challenges

Compliance and Adherence

Regular and consistent blood glucose monitoring is essential for effective diabetes management. However, some individuals may struggle with adherence, either due to forgetfulness, discomfort associated with testing, or a lack of motivation. Properly using self-monitoring blood glucose devices requires some level of technical skill and knowledge. Some elderly individuals or those with limited dexterity may find it challenging to operate the devices correctly. Self-monitoring blood glucose devices need to be accurately calibrated and maintained to provide reliable results. Incorrect calibration or using expired test strips can lead to inaccurate readings.

Low Rate of Diagnosis in Emerging Countries

The presence of a significant proportion of undiagnosed individuals with diabetes is a major contributing factor to the lower adoption of Blood Glucose Monitoring Systems, particularly in emerging countries. The prevalence of delayed diagnosis is higher in countries like China, India, South Africa, Brazil, and others, compared to developed nations. Additionally, limited awareness among the general population regarding chronic diseases such as diabetes mellitus, coupled with restricted access to advanced healthcare infrastructure and inadequate conventional procedures by government or private organizations, may impede growth.

For example, as per data published by the International Diabetes Federation in 2021, nearly half of the diabetes patients in Africa remain undiagnosed, while in the Asia Pacific region, the proportion of undiagnosed individuals with diabetes is around 55.0%, primarily driven by countries like India, China, and Indonesia. Thus, the aforementioned factors, alongside the absence of reimbursement plans for CGM & SMBG systems, significantly contribute to lower diagnosis and treatment rates, subsequently limiting the implementation of these systems in developing countries.

Key Market Trends

New Product Launches in the Market

Prominent companies operating in the self-monitoring blood glucose (SMBG) devices market are strategically focused on developing innovative technological solutions to enhance their market position. For instance, in August 2022, Intuity Medical, Inc., a commercial-stage medical technology and digital health company committed to simplifying life with diabetes, introduced the POGO Automatic® Blood Glucose Monitoring System at over 2,200 US pharmacies operated by Kroger Health, the healthcare division of The Kroger Co. The POGO Automatic from Intuity Medical is the sole FDA-approved automatic blood glucose monitor featuring 10-test cartridge technology, eliminating the need for individuals with diabetes to carry or load separate lancets and test strips. It effortlessly lances, collects blood, and provides a glucose result with just a touch of a button.

Increasing Funding and Investments

Boosting funding and investments will facilitate research and development activities, as well as new technology advancements and projects. Market players are securing funding and investments aimed at digital transformation for improved efficiency. For example, in September 2022, Transdermal Diagnostics, a UK-based technology platform dedicated to enhancing the prevention, diagnosis, and management of chronic conditions, announced the successful completion of their oversubscribed £1.1 million ($1.31 million) pre-seed investment round. This funding will be utilized to develop a cost-effective, 100% needle-free glucose monitor, improving access to affordable blood sugar monitoring and assisting diabetics in leading longer, healthier lives. With the aid of Transdermal Diagnostics' new technology, individuals with diabetes may potentially slow down or even halt the progression of their condition by painlessly monitoring their blood glucose levels. Furthermore, in May 2022, Labcorp, a leading global life sciences company and commercial laboratory, launched an at-home collection kit that measures hemoglobin A1c and assesses the risk of diabetes using a small blood sample.

Segmental Insights

End User Insights

The hospitals segment is projected to dominate the market during the forecast period, driven by the improving infrastructure and increasing healthcare expenditure in hospitals. Furthermore, BGM devices provide reliable data to practitioners within seconds, enhancing patient care quality in both outpatient and inpatient settings. Hospitals also have robust provisions for storing and transferring patient information. Additionally, in response to the COVID-19 pandemic, the FDA authorized the use of CGM devices in hospitals, and the potential for future pandemics is expected to further drive segment growth.

The home care segment is anticipated to exhibit the highest growth rate throughout the forecast period. Self-monitoring of blood glucose has revolutionized home-based glucose monitoring and is widely adopted worldwide as a short-term glucose monitoring method. Self-monitoring blood glucose (SMBG) allows individuals, with or without diabetes, to measure their blood sugar levels in the comfort of their homes. This approach enables patients to assess the effects of their treatment, including diet, insulin, exercise, and stress management, based on their blood glucose readings.

Application Insights

In terms of application, the market can be categorized into gestational, type 2, and type 1 diabetes. Type 2 diabetes holds the largest market share in the global self-monitoring blood glucose devices market. It is a chronic, lifelong condition that affects the processing and monitoring of sugar levels. Type 2 diabetes is the most common form of diabetes, accounting for the majority of diabetes cases globally. The rising prevalence of Type 2 diabetes, particularly due to lifestyle factors like sedentary habits, unhealthy diets, and obesity, is contributing to the expanding market for self-monitoring blood glucose devices. Effective management of Type 2 diabetes requires regular blood glucose monitoring. Self-monitoring blood glucose devices play a vital role in helping individuals with Type 2 diabetes track their glucose levels and make necessary adjustments to their treatment plans, contributing to the market growth.

Regional Insights

The escalating incidence and prevalence of diabetes patients, along with healthcare expenditure, in the United States indicate a growing utilization of Self-monitoring Blood Glucose (SMBG) devices. North America is projected to be the dominant market, driven by factors such as the widespread availability of SMBG devices, high consumer awareness, and favorable reimbursement policies. The prevalence of diabetes has witnessed a significant surge in the past two decades in North America, primarily attributed to the increased prevalence of obesity and lifestyle changes. Furthermore, the region exhibits higher carbohydrate consumption, which contributes to the rising obesity rates. The United States, within North America, represents one of the countries experiencing rapid growth in chronic diseases, and it stands as the largest demand-generating country for SMBG devices.

Key Market Players

• Abbott Laboratories
• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care
• Dexcom, Inc.
• Sanofi
• Novo Nordisk
• Insulet Corporation
• Ypsomed Holdings
• Glysens Incorporated

Report Scope:

In this report, the Global Self-monitoring Blood Glucose Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Self-monitoring Blood Glucose Devices Market, By Product:

• Self-monitoring Blood Glucose Devices Meters
• Continuous Glucose Monitors
• Testing Strips
• Lancets

Self-monitoring Blood Glucose Devices Market, By Application:

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Self-monitoring Blood Glucose Devices Market, By End User:

• Hospitals
• Home Settings,
• Diagnostic Centers

Self-monitoring Blood Glucose Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Self-monitoring Blood Glucose Devices Market.

Available Customizations:

Global Self-monitoring Blood Glucose Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Self-monitoring Blood Glucose Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets)
  • 5.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
  • 5.2.3. By End User (Hospitals, Home Settings, and Diagnostic Centres)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map

6. North America Self-monitoring Blood Glucose Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Self-monitoring Blood Glucose Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Self-monitoring Blood Glucose Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Self-monitoring Blood Glucose Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Self-monitoring Blood Glucose Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Self-monitoring Blood Glucose Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Self-monitoring Blood Glucose Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Self-monitoring Blood Glucose Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Self-monitoring Blood Glucose Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Self-monitoring Blood Glucose Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Self-monitoring Blood Glucose Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Self-monitoring Blood Glucose Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Self-monitoring Blood Glucose Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Self-monitoring Blood Glucose Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Self-monitoring Blood Glucose Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Self-monitoring Blood Glucose Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

12. Market Trends & Developments

13. Global Self-monitoring Blood Glucose Devices Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Product Offerings
• 14.3. Recent Developments
• 14.4. Key Personnel
• 14.5. SWOT Analysis
  • 14.5.1. Abbott Laboratories
  • 14.5.2. Medtronic plc
  • 14.5.3. F. Hoffmann-La Roche Ltd
  • 14.5.4. Ascensia Diabetes Care
  • 14.5.5. Dexcom, Inc.
  • 14.5.6. Sanofi
  • 14.5.7. Novo Nordisk
  • 14.5.8. Insulet Corporation
  • 14.5.9. Ypsomed Holdings
  • 14.5.10. Glysens Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer